SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DanZ who wrote (201)2/4/1999 8:14:00 PM
From: Bengalus  Read Replies (1) of 5582
 
Dan, perhaps I'm using "hype" too loosely. My sense is that the leading journals generally do not publish studies that have been discussed outside a scientific setting before publication. Gel Tech's press release, the Zicam website and related marketing materials do discuss the study's results.

Sometimes news of a study in Nature, for example, may be released a week early because it relates to something published in Science that week. Also, AIDS related research is often made quite public well before it appears in print. Generally, though, science publications treat research reports like news scoops, and they don't like someone else stealing their thunder.

Cold-Eeze was marketed before Macknin's Cleveland Clinic study in summer '96 based on Godfrey's Dartmouth College trials. But there was no leak of the Macknin study results until it had been published in the Annals of Internal Medicine.

I'm not trying to tell you what's reasonable, only what I believe to be the standard practice when it comes to this stuff.

I also agree that people buy homeopathic remedies without requiring results from a double-blind trial. But published trial results add the credibility that generates massive free publicity. Also, you can't claim something has been "clinically proven" to do anything until you have the study in print.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News